With extensive experience navigating the Medicare Advantage, Medicare Part D, and Medicaid managed care programs, Kate is regularly called on by health plans, provider organizations, technology start-ups, private equity funds, retailers and other clients to benchmark risks, solve regulatory challenges and structure transactions, particularly those that involve federal and state healthcare programs. As payors and providers continue to realign in today’s market, Kate has a nuanced understanding of the unique obstacles and opportunities facing companies at the intersection of these two worlds. She helps innovative companies navigate state risk-bearing regulations, drafts and negotiates agreements with complex reimbursement structures and regulatory implications, and advises healthcare companies and private equity funds on investments in highly-regulated segments of the healthcare market.

Kate is a contributing author to Regulation of Medicare Part D Plans (Thomson Reuters, 2019 edition) and Thomson Reuters Health Law Handbook (2017 edition). She speaks regularly at healthcare industry events, including the Wall Street Journal Health Forum, American Health Lawyers Association Institute for Health Plan Counsel, Blue Cross Blue Shield National Summit, Health Care Compliance Association Managed Care Compliance Conference, and Medicaid Managed Care Congress. Kate has been recognized in the Legal 500 United States (2019) and was the first recipient of the McDermott Will & Emery Client Service Award (2019).

Show Less

• Counseled Part D plans and pharmacy benefit managers on related party arrangements, Any Willing Pharmacy rules and prescription drug pricing reform.
• Evaluated proposed business arrangements between health insurers, providers and pharmacies for potential risks under the federal Anti-Kickback Statute, Beneficiary Inducement Civil Money Penalties Law and False Claims Act.
• Provided strategic advice regarding demonstration programs sponsored by the Center for Medicare & Medicaid Innovation.
• Drafted and negotiated provider, vendor and pharmacy benefit management agreements for health plans.
• Led a multidisciplinary regulatory due diligence team in connection with a $400 million acquisition of an independent medical group.
• Performed health regulatory due diligence on a provider organization specializing in high-touch in-home care for chronically ill patients.
• Represented numerous healthcare organizations, venture capital funds and private equity investors in connection with proposed investments in and acquisitions of health insurers and HMOs.

Show Less